Expert NetworkExpert InterviewAZN

Slingshot members are talking to an expert! The topic is:

Discussing the AMPLIFY Phase III trial of Calquence plus venetoclax as a first line treatment for chronic lymphocytic leukemia

Executed on:Aug 29, 2024 12:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: AHN Cancer Institute
  • Hematologist with the AHN Cancer Institute.
  • Currently manages 35 patients for CLL
  • Specializes in treating disorders and cancers of the blood, such as lymphoma, leukemia, myeloma and is involved in hematology research.

Interview Goal

This call will feature a discussion on the current treatment landscape and the potential of Calquence (acalabrutinib) in combination with venetoclax as a treatment for CLL.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.